Cerus Corporation - Common Stock — Flux de trésorerie trimestriel (NASDAQ:CERS)

Afficher le graphique complet Full chart

Financials

Total de l'actif 200.92 M206.78 M213.07 M215.19 M221.86 M222.91 M Total du passif 144.02 M150.53 M156.9 M152.98 M156.89 M154.62 M Total des capitaux propres 56.9 M56.24 M56.17 M62.2 M64.97 M68.29 M Total du passif et des capitaux propres 200.92 M206.78 M213.07 M215.19 M221.86 M222.91 M Dette totale 84.16 M84.97 M84.89 M84.9 M83.89 M84.83 M Dette nette 3.71 M4.05 M6.87 M6.39 M1.01 M4.41 M

Cerus Corporation - Common Stock

Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.

CERS

Financials

Cerus Corporation - Common Stock

Nouvelles

Cerus Corporation: Strong Q1 Results Validate The Turnaround Thesis (NASDAQ:CERS)

Top 3 Health Care Stocks That May Collapse This Month - Apellis Pharmaceuticals (NASDAQ:APLS), Avanos Med

Cerus Corporation (CERS) Q1 2026 Earnings Call Transcript

Jensen, directrice juridique de Cerus Corp, vend pour 187.000$ d’actions

Jensen, Cerus Corp chief legal officer, sells $187k in stock

Le directeur financier de Cerus Corp vend pour 211.000$ d’actions

Cerus Corp : le directeur médical Benjamin vend pour 168.000$ d’actions

Le COO de Cerus Corp, Jayaraman, vend pour 273.000$ d’actions

Le PDG de Cerus Corp, Greenman, vend pour 742.000$ d’actions

Cerus Corp COO Jayaraman sells $273k in shares

Cerus Corp CEO Greenman sells $742k in shares

Cerus Corp CFO green sells $211k in shares